NVET
Nexvet Biopharma plc Ordinary Shares
NVET
NVET
Delisted
NVET was delisted on the 28th of July, 2017.
17 hedge funds and large institutions have $23.8M invested in Nexvet Biopharma plc Ordinary Shares in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
2
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
LLC
Latimer Light Capital
New York
|
+$281K |
2 |
BC
Broadfin Capital
New York
|
+$71.6K |
3 |
UBS Group
Zurich,
Switzerland
|
+$13K |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3K |
Top Sellers
1 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
-$332K |
2 |
CI
Cowen Inc
New York
|
-$53.5K |
3 |
Bank of America
Charlotte,
North Carolina
|
-$9.02K |
4 |
Morgan Stanley
New York
|
-$3.35K |
5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$277 |